Biobanks, Data Sharing, and the Drive for a Global Privacy Governance Framework

Journal of Law, Medicine and Ethics

Volumn 43, Issue 4, 2015, Pages 675-689

  Dove, Edward S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXPECTATION; MEDICAL RESEARCH; PRIVACY; THINKING; WELFARE; BIOBANK; CONFIDENTIALITY; FACTUAL DATABASE; HUMAN; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; CONFIDENTIALITY; DATABASES, FACTUAL; HUMANS; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION;

EID: 84953211548     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/jlme.12311     Document Type: Article

References (147)

1. J. Vaught, M. Bledsoe, and P. Watson, "Biobanking on Multiple Continents: Will International Coordination Follow?" Biopreservation and Biobanking 12, no. 1 (2014): 1-2.
2. Biobank Lexicon, Public Population Project in Genomics and Society (P3G), available at (last visited October 12, 2015).
3. D. M. Shaw, B. S. Elger, and F. Colledge, "What Is a Biobank? Differing Definitions among Biobank Stakeholders," Clinical Genetics 85, no. 3 (2014): 223-227
4. F. S. Collins, "Reengineering Translational Science: The Time is Right, " Science Translational Medicine 3 no. 90 (2011): 90
5. B. M. Knoppers, From Genomic Databases to Translation: A Call to Action," Journal of Medical Ethics 37, no. 8 (2011): 515-516; J. R. Harris, "Toward a Roadmap in Global Biobanking for Health," European Journal of Human Genetics 20, no. 11 (2012): 1105-1101.
6. J. R. Harris, "Toward a Roadmap in Global Biobanking for Health," European Journal of Human Genetics 20, no. 11 (2012): 1105-1101.
7. M. Stranger and J. Kaye, "Governing Biobanks: An Introduction, " in J. Kaye and M. Stranger, eds., Principles and Practice in Biobank Governance (Surrey, UK: Ashgate, 2009): 1-16
8. R.P. Tracy, "'Deep Phenotyping': Characterizing Populations in the Era of Genomics and Systems Biology," Current Opinion in Lipidology 19, no. 2 (2008): 151-157.
9. M. Rezeli et al., "Biomarker Discovery Utilizing Biobanking Archives and the Diagnostic Market, " in G. Marko-Varga, ed., Genomics and Proteomics for Clinical Discovery and Development (Dordrecht: Springer, 2014): at 137-146
10. J. E. Olson et al., "Biobanks and Personalized Medicine, " Clinical Genetics 86, no. 1 (2014): 50-55.
11. E. Zika et al., "A European Survey on Biobanks: Trends and Issues, " Public Health Genomics 14, no. 2 (2011): 96-103.
12. Recommendation Rec(2006)4 of the Committee of Ministers to Member States on Research on Biological Materials of Human Origin, Council of Europe, (Council of Europe: Strasbourg, 2006), available at https://wcd.coe.int/wcd/ViewDoc.jsp?id=977859(last visited October 12, 2015).
13. Global Alliance for Genomics and Health, available at (last visited October 12, 2015).
14. K. G. Huang and F. E. Murray, "Entrepreneurial Experiments in Science Policy: Analyzing the Human Genome Project, " Research Policy 39, no. 5 (2010): 567-582.
15. E. S. Lander, "Initial Impact of the Sequencing of the Human Genome, " Nature 470, no. 7333 (2011): 187-197
16. J. N. Cooke Bailey, M. A. Pericak-Vance, and J. L. Haines, "The Impact of the Human Genome Project on Complex Disease," Genes 5, no. 3 (2014): 518-535.
17. M. D. Gisler, D. Sornette, and R. Woodard, "Innovation as a Social Bubble: The Example of the Human Genome Project, " Research Policy 40, no. 10 (2011): 1412-1425.
18. S. E. Hyman, "The Meaning of the Human Genome Project for Neuropsychiatric Disorders, " Science 331, no. 6020 (2011): 1026.
19. Y. Joly et al., "Data Sharing in the Post-Genomic World: The Experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO), " PLOS Computational Biology 8, no. 7 (2012): e1002549.
20. International Cancer Genome Consortium, available at (last visited October 12, 2015).
21. International Cancer Genome Consortium, "International Network of Cancer Genome Projects, " Nature 464, no. 7291X (2010): 993-998
22. Nik-Zainal S.et al., "Mutational Processes Molding the Genomes of 21 Breast Cancers," Cell 149, no. 5 (2012): 979-993
23. T. J. Hudson, "Genome Variation and Personalized Cancer Medicine," Journal of Internal Medicine 274, no. 5 (2013): 440-450.
24. X. Hu et al., "The Cancer Genomics and Global Cancer Genome Collaboration, " Science Bulletin 60, no. 1 (2015): 65-70
25. M. R. Stratton, P. J. Campbell, and P. A. Futreal, "The Cancer Genome," Nature 458, no. 7239 (2009): 719-724
26. J. B. Vaught, E. Caboux, and P. Hainaut, "International Efforts to Develop Biospecimen Best Practices," Cancer Epidemiology Biomarkers & Prevention 19, no. 4 (2010): 912-915.
27. D. R. C. Chalmers, D. Nicol, and M. F. Otlowski, "To Share or Not To Share Is the Question, " Applied & Translational Genomics 3, no. 4 (2014): 116-119; L. Ohno-Machado, "To Share or Not to Share: That Is Not the Question, " Science Translational Medicine 4 (2012): 165
28. B. M. Knoppers et al., "Towards a Data Sharing Code of Conduct for International Genomic Research, " Genome Medicine 3, no. 46 (2011): 46
29. Framework for Responsible Sharing of Genomic and Health-Related Data, Global Alliance for Genomics and Health, available at (last visited October 12, 2015).
30. E. S. Dove, G. T. Laurie, and B. M. Knoppers, "Data Sharing and Privacy, " in H. F. Willard and G. S. Ginsburg, eds., Genomic and Personalized Medicine, 3d ed., Vol. II, Translation and Implementation (Waltham: Elsevier, in press).
31. The Cancer Genome Atlas Research Network et al., "The Cancer Genome Atlas Pan-Cancer Analysis Project, " Nature Genetics 45, no. 10 (2013): 1113-1120
32. I. Fortier et al., "Is Rigorous Retrospective Harmonization Possible? Application of the DataSHaPER Approach across 53 Large Studies, " International Journal of Epidemiology 40, no. 5 (2011): 1314-1328
33. M. G. Hansson, "Biobanking within the European Regulatory Framework: Opportunities and Obstacles, " Biopreservation and Biobanking 9, no. 2 (2011): 165-167.
34. R. T. M. Chem et al., "RD-Connect: An Integrated Platform Connecting Databases, Registries, Biobanks and Clinical Bioinformatics for Rare Disease Research, " Journal of General Internal Medicine 29, no. 3 (2014): 780-787
35. E. J. Horn and H. M. Moore, "Overcoming Challenges in the Acquisition of Biospecimens for Rare Diseases, " Expert Opinion on Orphan Drugs 2, no. 1 (2014): 1-4
36. I. S. Kohane and A. Eran, "Can We Measure Autism?" Science Translational Medicine 5, no. 209 (2013): 209
37. S. F. Terry et al., "Advocacy Groups as Research Organizations: The PXE International Example, " Nature Reviews Genetics 8, no. 2 (2007): 157-164.
38. F. Colledge, B. Elger, and H. C. Howard, "A Review of the Barriers to Sharing in Biobanking, " Biopreservation and Biobanking 11, no. 6 (2013): 339-346;
39. J. Kaye and N. Hawkins, "Data Sharing Policy Design for Consortia: Challenges for Sustainability, " Genome Medicine 6, no. 1 (2014): 4
40. M. W. Foster and R. R. Sharp, "Share and Share Alike: Deciding How to Distribute the Scientific and Social Benefits of Genomic Data, " Nature Reviews Genetics 8, no. 8 (2007): 633-639.
41. Human Genome Organization (HUGO), "Summary of Principles Agreed Upon at the First International Strategy Meeting on Human Genome Sequencing (Bermuda, 25-28 February 1996) as reported by HUGOPrinciples Agreed at the First International Strategy Meeting on Human Genome Sequencing: 25-28 February 1996 (Bermuda, 1996), " available at (last visited October 12, 2015)
42. Wellcome Trust, Sharing Data from Large-Scale Biological Research Projects: A System of Tripartite Responsibility (2003), available at (last visited October 12, 2015)
43. Toronto International Data Release Workshop Authors et al., "Prepublication Data Sharing, " Nature 461, no. 7261 (2009): 168-170
44. Wellcome Trust, Sharing Research Data to Improve Public Health: Full Joint Statement by Funders of Health Research (2011), available at (last visited October 12, 2015).
45. Nuffield Council on Bioethics, The Collection, Linking and Use of Data in Biomedical Research and Health Care: Ethical Issues (London: Nuffield Council on Bioethics, 2015), available at (last visited October 23, 2015).
46. S. Warren and L. Brandeis, "The Right to Privacy, " Harvard Law Review 4, no. 5 (1890): 193-220
47. J. Q. Whitman, "The Two Western Cultures of Privacy: Dignity Versus Liberty," Yale Law Journal 113, no. 1151 (2004): 1151-1221
48. World Medical Association, Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects (2013), available at <> (last visited October 13, 2015). http://www.wma.net/en/30publications/10policies/b3/
49. The right to privacy and the right to respect for private life may be seen as overlapping but distinct rights. Generally, the latter right is seen as more expansive than the former. See L. A. Bygrave, "Data Protection Pursuant to the Right to Privacy in Human Rights Treaties, " International Journal of Law and Information Technology 6, no. 3 (1998): 247-284
50. N. A. Moreham, "The Right to Respect for Private Life in the European Convention on Human Rights: A Re-examination, " European Human Rights Law Review 1, no. 44 (2008): 44-79.
51. European Union, Charter of Fundamental Rights of the European Union (2010), at Art. 8(1), available at (last visited October 13, 2015).
52. G. Laurie et al., "Managing Access to Biobanks: How Can We Reconcile Individual Privacy and Public Interests in Genetic Research?" Medical Law International 10 (2010): 315-337, at 317.
53. A. L. Allen, "Genetic Privacy: Emerging Concepts and Values," in M. A. Rothstein, ed., Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era (New Haven: Yale University Press, 1997): at 31-59.
54. Y. Wang, Human Population Genetic Research in Developing Countries: The Issue of Group Protection (Oxford: Routledge, 2014): at 121
55. J. L. McGregor, "Population Genomics and Research Ethics with Socially Identifiable Groups," Journal of Law Medicine & Ethics 35, no. 3 (2007): 356-370.
56. Y. Joly, I. N. Feze, and J. Simard, "Genetic Discrimination and Life Insurance: A Systematic Review of the Evidence, " BMC Medicine, 11, no. 25 (2013): 25
57. M. A. Rothstein and Y. Joly, "Genetic Information and Insurance Underwriting: Contemporary Issues and Approaches in the Global Economy, " in P. Atkinson, P. Glasner, and M. Lock, eds., The Handbook of Genetics & Society: Mapping the New Genomic Era (New York: Routledge, 2009): at 127-144.
58. J. Kaye, "The Tension Between Data Sharing and the Protection of Privacy in Genomics Research, " in D. Mascalzoni, ed., Ethics, Law and Governance of Biobanking: National, European and International Approaches (Dordrecht: Springer, 2015): 101-120
59. C. Heeney, "Assessing the Privacy Risks of Data Sharing in Genomics," Public Health Genomics 14, no. 1 (2011): 17-25.
60. G. Laurie et al., A Review of Evidence Relating to Harm Resulting from Uses of Health and Biomedical Data, June 30, 2014, report prepared for the Nuffield Council on Bioethics Working Party on Biological and Health Data and the Expert Advisory Group on Data Access, available at (last visited October 13, 2015).
61. M. Otlowski, S. Taylor, and Y. Bombard, "Genetic Discrimination: International Perspectives, " Annual Review of Genomics and Human Genetics 13 (2012): 433-454
62. G. Quinn, A. de Paor, and P. Blanck, Genetic Discrimination: Transatlantic Perspectives on the Case for a European-level Legal Response (Milton Park: Routledge, 2015) S.B. 559, Reg. Sess. (Cal. 2010-2011), available at (last visited October 13, 2015); Genetic Information Nondiscrimination Act of 2008, Pub. L. 110-233, 122 Stat. 881 (2008).
63. B. M. Knoppers and R. Chadwick, "Human Genetic Research: Emerging Trends in Ethics, " Nature Reviews Genetics 6, no. 1 (2005): 75-79; R. Chadwick, "The Communitarian Turn: Myth or Reality?" Cambridge Quarterly of Healthcare Ethics 20, no. 4 (2011): 546-553.
64. R. Chadwick, "The Communitarian Turn: Myth or Reality?" Cambridge Quarterly of Healthcare Ethics 20, no. 4 (2011): 546-553.
65. J. E. McEwen, J. T. Boyer, and K. Y. Sun, "Evolving Approaches to the Ethical Management of Genomic Data, " Trends in Genetics 29, no. 6 (2013): 375-382; Y. Erlich et al., "Redefining Genomic Privacy: Trust and Empowerment, " PLOS Biology 12 (2014): e1001983
66. W. W. Lowrance, Learning from Experience Privacy and the Secondary Use of Data in Health Research (London: Nuffield Trust, 2002): at 34; Guidance for Industry: E15 Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories, ICH (April 2008), available at (last visited October 13, 2015)
67. Data Protection Working Party, Opinion 05/2014 on Anonymization Techniques (April 10, 2014), available at (last visited October 13, 2015).
68. B. M. Knoppers, M. H. Zawati, and E. S. Kirby, "Sampling Populations of Humans across the World: ELSI Issues, " Annual Review of Genomics and Human Genetics 13 (2012): 395-413, at 400.
69. J. Kaye et al., "Dynamic Consent: A Patient Interface for Twenty-First Century Research Networks, " European Journal of Human Genetics 23, no. 2 (2015): 141-146
70. K. S. Steinsbekk, B. K. Myskja, and B. Solberg, "Broad Consent versus Dynamic Consent in Biobank Research: Is Passive Participation an Ethical Problem?" European Journal of Human Genetics 21, no. 9 (2013): 897-902.
71. Broad consent can be defined as consent for an unspecified range of future research subject to a few content and/or process restrictions. See Christine Grady et al., "Broad Consent for Research With Biological Samples: Workshop Conclusions, " American Journal of Bioethics 15, no. 9 (2015): 34-42.
72. K. Melham et al., "The Evolution of Withdrawal: Negotiating Research Relationships in Biobanking, " Life Sciences, Society and Policy 10, no. 16 (2014): 1-13.
73. J. Sándor and P. Bárd, "Anonymity and Privacy in Biobanking, " in C. Lenk, J. Sándor, B. Gordijn, eds., Biobanks and Tissue Research: The Public, the Patient and the Regulation (Dordrecht: Springer, 2011): 213-230.
74. J. Kaye et al., "Can I Access My Personal Genome? The Current Legal Position in the UK, " Medical Law Review 22, no. 1 (2014): 64-86.
75. Y. Erlich and A. Narayanan, "Routes for Breaching and Protecting Genetic Privacy, " Nature Reviews Genetics 15, no. 6 (2014): 409-421
76. W. W. Lowrance and F. S. Collins, "Identifiability in Genomic Research, " Science 317, no. 5838 (2007): 600-602
77. D. Greenbaum et al., "Genomics and Privacy: Implications of the New Reality of Closed Data for the Field, " PLOS Computational Biology 7, no. 12 (2011): e1002278.
78. R. Gan et al., "Chinese Biobanking Initiatives, " Biopreservation and Biobanking 13, no. 1 (2015): 4-7, at 6, noting that the China National Gene-Bank (CNGB) in Shenzhen has collected more than 1.5 million traceable biospecimens and has stored 20 petabytes of data.
79. Z. Lin, A. B. Owen, and R. B. Altman, "Genomic Research and Human Subject Privacy, " Science 305, no. 5681 (2004): 183
80. B. Malin and L. Sweeney, "How (Not) to Protect Genomic Data Privacy in a Distributed Network: Using Trail Re-identification to Evaluate and Design Anonymity Protection Systems, " Journal of Biomedical Informatics 37, no. 3 (2004): 179
81. N. Homer et al., "Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping Microarrays, " PLOS Genetics, 4, no. 8 (2008): e1000167
82. D. R. Nyholt, C.-E.Yu, and P. M. Visscher, "On Jim Watson's APOE Status: Genetic Information Is Hard to Hide, " European Journal of Human Genetics 17, no. 2 (2009): 147-149
83. H. K. Im et al., "On Sharing Quantitative Trait GWAS Results in an Era of Multiple-Omics Data and the Limits of Genomic Privacy, " American Journal of Human Genetics 90, no. 4 (2012): 591-598
84. E. E. Schadt, S. Woo, and K. Hao, "Bayesian Method to Predict Individual SNP Genotypes from Gene Expression Data, " Nature Genetics 44, no. 5 (2012): 603-660
85. D. J. Kaufman et al., "Public Opinion about the Importance of Privacy in Biobank Research, " American Journal of Human Genetics 85, no. 5 (2009): 643-654
86. L. Ursin and K. S. Steinsbekk, "Peeking into the Black Box of Privacy - Biobank Participants on the Importance of Recognition, " Norsk Epidemiologi 21, no. 2 (2012): 269-276
87. M. A. Igbe and C. A. Adebamowo, "Qualitative Study of Knowledge and Attitudes to Biobanking among Lay Persons in Nigeria, " BMC Medical Ethics 13, no. 27 (2012)
88. A. K. Rahm et al., "Biobanking for Research: A Survey of Patient Population Attitudes and Understanding, " Journal of Community Genetics 4, no. 4 (2013): 445-450l
89. J. Starkbaum et al., "Public Perceptions of Cohort Studies and Biobanks in Germany, " Biopreservation and Biobanking 12, no. 2 (2014): 121-130
90. M. Ahram et al., "Factors Influencing Public Participation in Biobanking, " European Journal of Human Genetics 22, no. 4 (2014): 445-451.
91. M. A. Franc et al., "Coding of DNA Samples and Data in the Pharmaceutical Industry: Current Practices and Future Directions - Perspective of the I-PWG, " Clinical Pharmacology & Therapeutics 89, no. 4 (2011): 537-545.
92. M. A. Rothstein, "Is Deidentification Sufficient to Protect Health Privacy in Research?" American Journal of Bioethics 10, no. 9 (2010): 3-11; Erlich et al., supra note 40.
93. E. S. Dove et al., "Genomic Cloud Computing: Legal and Ethical Points to Consider, " European Journal of Human Genetics 23, no. 10 (2015): 1271-1278.
94. M. Wjst, "Caught You: Threats to Confidentiality Due to the Public Release of Large-Scale Genetic Data Sets, " BMC Medical Ethics 11, no. 21 (2010).
95. E. S. Dove, "The Genetic Privacy Carousel: A Discourse on Proposed Genetic Privacy Bills and the Co-Evolution of Law and Science, " Current Pharmacogenomics and Personalized Medicine 9, no. 4 (2011): 252-263
96. I. Budin-Ljøsne et al., "ELSI Challenges and Strategies of National Biobank Infrastructures, " Norsk Epidemiologi 21, no. 2 (2012): 155-160
97. E. Rial-Sebbag and A. Cambon-Thomsen, "The Emergence of Biobanks in the Legal Landscape: Towards a New Model of Governance, " Journal of Law and Society 39, no. 1 (2012): 113-130
98. E. S. Dove et al., "Charting the Privacy Landscape in Canadian Paediatric Biobanks, " Health Law Journal 20 (2013): 1-46
99. J. S. Forsberg and S. Soini, "A Big Step for Finnish Biobanking, " Nature Reviews Genetics 15, no. 6 (2014)
100. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada (Ottawa: Interagency Secretariat on Research Ethics, 2014), available at (last visited October 13, 2015)
101. NIH Genomic Data Sharing Policy, National Institutes of Health, available at (last visited October 13, 2015).
102. B. M. Knoppers et al., "A Human Rights Approach to an International Code of Conduct for Genomic and Clinical Data Sharing, " Human Genetics 133, no. 7 (2014): 895-903
103. I. Budin-Ljøsne et al., "Data Sharing in Large Research Consortia: Experiences and Recommendations from ENGAGE, " European Journal of Human Genetics 22 (2014): 317-321
104. T. Schulte In den Bäumen et al., "Data Protection and Sample Management in Biobanking - A Legal Dichotomy, " Genomics, Society and Policy 6, no. 1 (2010): 33-46
105. J. Kaye, "From Single Biobanks to International Networks: Developing e-Governance, " Human Genetics 130, no. 3 (2011): 377-382
106. D. Chalmers, "Genetic Research and Biobanks, " Methods in Molecular Biology 675 (2011): 1-37
107. B. S. Elger and A. L. Caplan, "Consent and Anonymization in Research Involving Biobanks: Differing Terms and Norms Present Serious Barriers to an International Framework, " EMBO Reports 7, no. 7 (2006): 661-666
108. B. M. Knoppers and M. Saginur, "The Babel of Genetic Data Terminology, " Nature Biotechonlogy 23, no. 8 (2005): 925-927
109. P. Burton, I. Fortier, and B. M. Knoppers, "The Global Emergence of Epidemiological Biobanks: Opportunities and Challenges, " in M. Khoury et al., eds., Human Genome Epidemiology: Building the Evidence for Using Genetic Information to Improve Health and Prevent Disease, 2d ed. (New York: Oxford University Press, 2009): 77-100.
110. OECD Guidelines on the Protection of Privacy and Transborder Flows of Personal Data, Organisation for Economic Cooperation and Development (OECD) (1980), at Preamble ('[T]here is a danger that disparities in national legislations could hamper the free flow of personal data across frontiers'), available at (last visited October 13, 2015).
111. Proposal for a Regulation of the European Parliament and of the Council on the Protection of Individuals with Regard to the Processing of Personal Data and on the Free Movement of Such Data (General Data Protection Regulation), European Commission, January 25, 2012, available at (last visited October 13, 2015)
112. P. Kosseim et al., "Building a Data Sharing Model for Global Genomic Research, " Genome Biology 15, no. 430 (2014)
113. M. Kiehntopf and M. Krawczak, "Biobanking and International Interoperability: Samples," Human Genetics 130, no. 3 (2011): 369-376.
114. R. H. Weber, "Transborder Data Transfers: Concepts, Regulatory Approaches and New Legislative Initiatives, " International Data Privacy Law 3, no. 2 (2013): 117-130, at 118-119.
115. L. Briceño Moraia et al. "A Comparative Analysis of the Requirements for the Use of Data in Biobanks based in Finland, Germany, the Netherlands, Norway and the United Kingdom, " Medical Law International 14, no. 4 (2014): 187-212. See also Burton, Fortier, Knoppers, supra note 62.
116. E. S. Dove, B. M. Knoppers, M. H. Zawati, "Towards an Ethics Safe Harbor for Global Biomedical Research, " Journal of Law and the Biosciences 1, no. 1 (2014): 3-51, at 16-17.
117. T. Lemmens and L. M. Austin, "The End of Individual Control over Health Information: Governing Biobanks and Promoting Fair Information Practices, " in Kaye and Stranger, supra note 5, at 243-266.
118. L. M. Austin and T. Lemmens, "Privacy, Consent, and Governance, " in K. Dierickx and P. Borry, eds., New Challenges for Biobanks: Ethics, Law and Governance (Antwerpen: Intersentia, 2009): at 111-122.
119. M. Yeo, Looking Out from Inside the Panopticon: A Privacy Perspective on Biobanking, analytic paper commissioned by the Office of the Privacy Commissioner of Canada for 29th International Conference of Data Protection and Privacy Commissioners (2007), at 33, available at .
120. U. M. Gassner, "Legal Aspects of Tissue Banking, " Pathobiology 74, no. 4 (2007): 270-274.
121. M. N. Fransson et al., "Toward a Common Language for Biobanking, " European Journal of Human Genetics 23, no. 1 (2015): 22-28
122. M. Verlinden et al., "Access to Biobanks: Harmonization Across Biobank Initiatives, " Biopreservation and Biobanking 12, no. 6 (2014): 415-422
123. G. Gunasekara, "Paddling in Unison or Just Paddling? International Trends in Reforming Information Privacy Law, " International Journal of Law and Information Technology 22, no. 2 (2014): 141-177
124. A.-M. Tassé, "From ICH to IBH in Biobanking? A Legal Perspective on Harmonization, Standardization and Unification, " Studies in Ethics, Law, and Technology 7, no. 1 (2013): 1-15
125. D. Doiron et al., "Data Harmonization and Federated Analysis of Population-Based Studies: The BioSHaRE Project, " Emerging Themes in Epidemiology 10, no. 1 (2013): 12
126. G. Greenleaf, "The Influence of European Data Privacy Standards outside Europe: Implications for Globalization of Convention 108, " International Data Privacy Law 2, no. 2 (2012): 68-92
127. Cécile de Terwangne, "Is a Global Data Protection Regulatory Model Possible?" in S. Gutwirth et al., eds., Reinventing Data Protection? (Dordrecht: Springer, 2009): 175-189
128. E15 Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories, International Conference on Harmonization (ICH) (2007), available at (last visited October 13, 2015).
129. B. M. Knoppers, M. H. Abdul-Rahman, and K. Bédard, "Genomic Databases and International Collaboration, " King's Law Journal 18, no. 2 (2007): 291-312.The Global Alliance for Genomics and Health has developed a table of concordance of data privacy mechanisms
130. Global Alliance for Genomics and Health, Privacy and Security Policy, available at (last visited October 23, 2015).
131. P. De Hert and V. Papakonstantinou, "The Proposed Data Protection Regulation Replacing Directive 95/46/EC: A Sound System for the Protection of Individuals, " Computer Law & Security Review 28, no. 2 (2012): 130-142
132. L. Costa and Y. Poullet, "Privacy and the Regulation of 2012, " Computer Law & Security Review 28, no. 3 (2012): 254-262
133. P. Blume, "The Myths Pertaining to the Proposed General Data Protection Regulation, " International Data Privacy Law 4, no. 4 (2014): 269-273, at 271-272.
134. R. Fears et al., "Data Protection Regulation and the Promotion of Health Research: Getting the Balance Right, " QJM: An International Journal of Medicine 107, no. 1 (2014): 3-5
135. N. Sethi, "The Promotion of Data Sharing in Pharmacoepidemiology, " European Journal of Health Law 21, no. 3 (2014): 271-296
136. E. S. Dove, D. Townend, and B. M. Knoppers, "Data Protection and Consent to Biomedical Research: A Step Forward?" The Lancet 384, no. 9946 (2014): 855
137. C. T. Di Iorio, F. Carinci, and J. Oderkirk, "Health Research and Systems' Governance are at Risk: Should the Right to Data Protection Override Health?" Journal of Medical Ethics 40, no. 7 (2014): 488-492
138. P.G. Casali et al., "Risks of the New EU Data Protection Regulation: An ESMO Position Paper Endorsed by the European Oncology Community, " Annals of Oncology 25, no. 8 (2014): 1458-1461
139. M. C. Ploem, M. L. Essink-Bot, and K. Stronks, "Proposed EU data Protection Regulation Is a Threat to Medical Research, " BMJ 346, no. f3534 (2013): f3534.
140. International Standards on the Protection of Personal Data and Privacy: The Madrid Resolution, International Conference of Data Protection and Privacy Commissioners (2009),http://www.privacycommission.be/sites/privacycommission/files/documents/international_standards_madrid_2009.pdf> (last visited October 13, 2015).
141. M. C. Gibbons et al., "Governing Genetic Databases: Challenges Facing Research Regulation and Practice, " Journal of Law and Society 34, no. 2 (2007): 163-189; J. Kaye, "Do We Need a Uniform Regulatory System for Biobanks across Europe?" European Journal of Human Genetics 14, no. 2 (2006): 245-248.
142. J. Kaye, "Do We Need a Uniform Regulatory System for Biobanks across Europe?" European Journal of Human Genetics 14, no. 2 (2006): 245-248.
143. Public Population Project in Genomics and Society (P3G), available at
144. Biobanking and BioMolecular resources Research Infrastructure-European Resources Research Infrastructure Consortium (BBMRI-ERIC), available at (last visited October 13, 2015).
145. Biobank Standardization and Harmonization for Research Excellence in the European Union (BioSHaRE), available at (last visited October 13, 2015).
146. International Society for Biological and Environmental Repositories (ISBER), available at (last visited October 13, 2015).
147. E. S. Dove and M. Phillips, "Privacy Law, Data Sharing Policies, and Medical Data: A Comparative Perspective, " in G. Loukides and A. Gkoulalas-Divanis, eds., Medical Data Privacy Handbook (Dordrecht: Springer, in press).